These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2460779)

  • 21. Imaging of brain tumors using peripheral benzodiazepine receptor ligands.
    Black KL; Ikezaki K; Toga AW
    J Neurosurg; 1989 Jul; 71(1):113-8. PubMed ID: 2544689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of gliomas in rat and man.
    Wilson CB; Hoshino T; Barker M; Downey R
    Prog Exp Tumor Res; 1972; 17():363-72. PubMed ID: 5082333
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis.
    Hasegawa H; Allen JC; Mehta BM; Shapiro WR; Posner JB
    Neurology; 1979 Sep; 29(9 Pt 1):1280-6. PubMed ID: 573408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
    Inamura T; Nomura T; Bartus RT; Black KL
    J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of mannitol infusions into the internal carotid artery on entry of two antibiotics into the cerebrospinal fluid and brains of normal rabbits.
    Perkins BA; Strausbaugh LJ
    Antimicrob Agents Chemother; 1983 Sep; 24(3):339-42. PubMed ID: 6416160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
    Waldman FM; Chew K; Ljung BM; Goodson W; Hom J; Duarte LA; Smith HS; Mayall B
    Mod Pathol; 1991 Nov; 4(6):718-22. PubMed ID: 1724086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
    Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell kinetics of human gliomas.
    Hoshino T; Barker M; Wilson CB; Boldrey EB; Fewer D
    J Neurosurg; 1972 Jul; 37(1):15-26. PubMed ID: 4338689
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
    Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
    J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors.
    Abe T; Wakimoto H; Bookstein R; Maneval DC; Chiocca EA; Basilion JP
    Cancer Gene Ther; 2002 Mar; 9(3):228-35. PubMed ID: 11896438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
    Black KL; King WA; Ikezaki K
    J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T; Hoshino T
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain.
    Chen KB; Wei VC; Yen LF; Poon KS; Liu YC; Cheng KS; Chang CS; Lai TW
    Neuroreport; 2013 Apr; 24(6):303-7. PubMed ID: 23426109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
    Zeymer U; Fishbein MC; Forrester JS; Cercek B
    Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake of boron into human gliomas of athymic mice and into syngeneic cerebral gliomas of rats after intracarotid infusion of sulfhydryl boranes.
    Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Dubois T; Velez C
    Basic Life Sci; 1989; 50():325-32. PubMed ID: 2535636
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of bromodeoxyuridine-immunohistochemistry to identify transplanted fetal brain tissue.
    Brown DB; Stanfield BB
    J Neural Transplant; 1989; 1(3-4):135-9. PubMed ID: 2519541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the use of bromodeoxyuridine and [3H]thymidine in studies of the cell cycle.
    Cawood AH; Savage JR
    Cell Tissue Kinet; 1983 Jan; 16(1):51-7. PubMed ID: 6825156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
    Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
    No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.